Two CHOP researchers were selected by the health and science news outlet STAT as 2023 Wunderkinds, an award that celebrates the next generation of scientific superstars.

Antibiotic use in neonatal intensive care units (NICUs) decreased substantially over the past decade, according to CHOP researchers.

CHOP and Penn researchers have received a $50 million grant from the NIH to study the impact of environmental influences on pregnancy and children’s health.

Dr. Eric Eichenwald, CHOP’s Division Chief of Neonatology, co-authored the first national standards for neonatal care published by the American Academy of Pediatrics (AAP).

Neonatal resuscitation is a high acuity, low occurrence event. Limited high-quality evidence informs neonatal resuscitation treatment recommendations.

In the midst of a busy day providing hands-on clinical care and developmental evaluations to vulnerable babies and children in our Neonatal Follow-up Program (NFP), there is another less visible but vital activity: research.

In this article, we review a case of a preterm infant with severe bronchopulmonary dysplasia (BPD), a history of S. aureus pneumonia, and subsequent large pneumatocele, managed with a less typical treatment modality.

Late-onset sepsis is a significant cause of morbidity and mortality among very preterm infants.

CHOP has a core team that performs immediate stabilization and resuscitation of high-risk infants during the time immediately after birth.

Since infants rely on antibodies passed from mother to baby during pregnancy, the findings suggest a need for alternative strategies for boosting infant immunity in the event of an outbreak.